Calcium and Phosphate Metabolism in Sarcoidosis

  • C. Alberts
  • H. van den Berg
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 178)


Hypercalciuria with or without hypercalcemia is a well-known disorder in sarcoidosis. Recent reports have focused attention on 1,25 — dihydroxyvitamin D causing the abnormal calcium metabolism. (1,2,3,4) Most studies have looked at small numbers of patients with manifest calcium disturbances.


Urinary Calcium Excretion Renal Handl Abnormal Calcium Abnormal Parathyroid Gland Phosphate Threshold 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    S.E. Papapoulos, L.J. Fraher, L.M. Sandler, T.L. Clemens, I.G. Lewin and J.L.H. O’Riordan, 1,25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis, Lancet 1: 627–630 (1979).PubMedCrossRefGoogle Scholar
  2. 2.
    N.H. Bell, P.H. Stern, E. Pantzer, T.K. Sinha and H.F. DeLuca, Evidence that increased circulating 1a,25-di.hydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis, J. Clin. Invest. 64: 218–225 (1979).PubMedCrossRefGoogle Scholar
  3. 3.
    P.H. Stern, J. de Olazabal and N.H. Bell, Evidence for abnormal regulation of circulating la,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism, J. Clin. Invest. 66: 852–855 (1980).PubMedCrossRefGoogle Scholar
  4. 4.
    Y. Koide, N. Kugai, S. Kimura, T. Fujita, N. Yamashita, T. Hiramoto, J. Sukegawa, E. Ogata and K. Yamashita, Increased 1,25-dihydroxycholecalciferol as a cause of abnormal calcium metabolism in sarcoidosis, J. Clin. Endocr. Met. 52: 494–498 (1981).CrossRefGoogle Scholar
  5. 5.
    R.J. Walton and O.L.M. Bijvoet, Nomogram for derivation of renal threshold phosphate concentration, Lancet 2: 309 (1975).PubMedCrossRefGoogle Scholar
  6. 6.
    P. Lips, W.H.L. Hackeng, M.J.M. Jongen, F.C. van Ginkel and J.C. Netelenbos, Seasonal variation in serum concentrations of parathyroid hormone in elderly people, J. Clin. Endocr. Met. 57 (1983 - in press).Google Scholar
  7. 7.
    S. Edelstein, M. Charman, D.E.M. Lawson and E. Kodicek, Competitive protein-binding assay for 25-hydroxycholecalciferol, Clin. Sci. and Mol. Med. 46: 231–240 (1974).Google Scholar
  8. 8.
    M.J.M. Jongen, W.J.F. van der Vijgh, H.J.J. Willems, J.C. Netelenbos and P. Lips, Simultaneous determination of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, and 1,25-dihydroxyvitamin D in plasma or serum, Clin. Chem. 27: 1757–1760 (1981).Google Scholar
  9. 9.
    M.J.M. Jongen, W.J.F. van der Vijgh, H.J.J. Willems and J.C. Netelenbos, Analysis for 1,25-dihydroxyvitamin D in human plasma, after a liquid-chromatographic purification procedure, with a modified competitive protein-binding assay, Clin. Chem. 27: 444–450 (1981).Google Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • C. Alberts
    • 1
    • 2
  • H. van den Berg
    • 1
    • 2
  1. 1.Department of PulmonologyUniversity Hospital (AZUA)AmsterdamThe Netherlands
  2. 2.Department of Clinical BiochemistryInstitute (CIVO) of Toxicology and Nutrition (TNO)ZeistThe Netherlands

Personalised recommendations